rosiglitazone has been researched along with Dermatosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, DJ; Denton, CP; Eastwood, M; Leask, A; Shi-wen, X; Stratton, RJ | 1 |
1 other study(ies) available for rosiglitazone and Dermatosclerosis
| Article | Year |
|---|---|
Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts.
Topics: Actins; Adult; Cells, Cultured; Female; Fibroblasts; Fibrosis; Humans; Male; Middle Aged; Phenotype; PPAR gamma; Rosiglitazone; Scleroderma, Localized; Skin; Thiazolidinediones | 2010 |